Company intelligence
eXmoor Pharma
Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From CMC Strategy to GMP Manufacturing & Facility Design
About eXmoor Pharma
eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across Viral Vectors, Autologous & Allogeneic Cell Therapies, and RNA Technologies. Unlike traditional CDMOs, we offer flexibility, full transparency, and IP freedom, ensuring you remain in control of your therapy’s future. Trusted by Industry Leaders Long-term partnerships define our success—70% of our clients return for ongoing collaboration. From academic innovators to biotech spin-outs and global pharma companies, we provide the expertise, infrastructure, and strategic foresight to transform groundbreaking science into life-changing therapies. Our Culture: Collaboration, Innovation, and Impact Much like our client relationships, our work culture is built on capability, collaboration, and trust. We create an environment where expertise thrives, encouraging innovation, continuous learning, and cross-functional teamwork. Our team works side by side, sharing knowledge and insights to drive the future of cell and gene therapy. Rooted in transparency, problem-solving, and scientific excellence, our culture empowers people to grow, lead, and make a meaningful impact in an evolving industry. Where Consultancy Leads and GMP Delivers. Your CGT CDMO Partner. To learn more about eXmoor Pharma, visit our website: www.exmoorpharma.com and to join our team visit: www.exmoorpharma.com/careers
Verified activity
Signals from eXmoor Pharma
6 published signals
Products & Services
eXmoor Pharma supported a team managing a Pharmaceutical Quality System with a risk-based approach to raw materials and supplier oversight, hands-on audit support, and the development of a written Contamination Control Strategy.
Reported by eXmoor Pharma
Presence & Recognition
eXmoor Pharma is exhibiting at Advanced Therapies Europe 2026 in Barcelona at stand 38, featuring Manuel BALBUENA and Robert Scott.
Reported by eXmoor Pharma
Customers & Market
eXmoor Pharma has clients that are CGT developers with programmes before commercialization.
Reported by Drew Hope
Presence & Recognition
eXmoor Pharma produced a short Q&A video featuring Senior Bio Manufacturing & Compliance Consultant and UK Qualified Person Drew Hope explaining why QP support extends into wider quality operations.
Reported by eXmoor Pharma
Presence & Recognition
eXmoor Pharma will be exhibiting at stand 38 at Advanced Therapies Europe 2026 in Barcelona from 7 to 9 September.
Reported by eXmoor Pharma
Presence & Recognition
eXmoor Pharma CEO Lucy Foley is attending the ISCT, International Society for Cell & Gene Therapy Asia 2026 meeting in Singapore.
Reported by eXmoor Pharma